NCT00001197View on ClinicalTrials.gov

Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia

PHASE2CompletedINTERVENTIONAL

Enrollment

41

Participants

Timeline

Start Date

February 7, 1984

Primary Completion Date

December 21, 2003

Study Completion Date

May 18, 2015

Conditions

Sickle Cell Anemia

Interventions

DRUG

Hydroxyurea

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH